214 related articles for article (PubMed ID: 12769789)
21. Kaposi's sarcoma and other manifestations of human herpesvirus 8.
Geraminejad P; Memar O; Aronson I; Rady PL; Hengge U; Tyring SK
J Am Acad Dermatol; 2002 Nov; 47(5):641-55; quiz 656-8. PubMed ID: 12399755
[TBL] [Abstract][Full Text] [Related]
22. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S
Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770
[TBL] [Abstract][Full Text] [Related]
23. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma.
Schalling M; Ekman M; Kaaya EE; Linde A; Biberfeld P
Nat Med; 1995 Jul; 1(7):707-8. PubMed ID: 7585156
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Cesarman E; Knowles DM
Semin Diagn Pathol; 1997 Feb; 14(1):54-66. PubMed ID: 9044510
[TBL] [Abstract][Full Text] [Related]
25. The role of human immunodeficiency virus-I in the pathogenesis of acquired immunodeficiency syndrome-related Kaposi's sarcoma: the importance of an inflammatory and angiogenic milieu.
Dezube BJ
Semin Oncol; 2000 Aug; 27(4):420-3. PubMed ID: 10950368
[TBL] [Abstract][Full Text] [Related]
26. The role of vascular endothelial growth factor (VEGF) in AIDS-related Kaposi's sarcoma.
Arastéh K; Hannah A
Oncologist; 2000; 5 Suppl 1():28-31. PubMed ID: 10804088
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation.
Merat R; Amara A; Lebbe C; de The H; Morel P; Saib A
Int J Cancer; 2002 Feb; 97(6):791-5. PubMed ID: 11857356
[TBL] [Abstract][Full Text] [Related]
28. Linking KSHV to human cancer.
Wong EL; Damania B
Curr Oncol Rep; 2005 Sep; 7(5):349-56. PubMed ID: 16091195
[TBL] [Abstract][Full Text] [Related]
29. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits HIV-1 Tat-induced angiogenesis in Kaposi's sarcoma cells.
Lu CX; Li J; Sun YX; Qi X; Wang QJ; Xin XL; Geng MY
Biochem Pharmacol; 2007 Nov; 74(9):1330-9. PubMed ID: 17868650
[TBL] [Abstract][Full Text] [Related]
30. Sustained angiogenesis enables in vivo transplantation of mucocutaneous derived AIDS-related Kaposi's sarcoma cells in murine hosts.
Mallery SR; Pei P; Kang J; Zhu G; Ness GM; Schwendeman SP
Carcinogenesis; 2000 Sep; 21(9):1647-53. PubMed ID: 10964095
[TBL] [Abstract][Full Text] [Related]
31. Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders.
Aoki Y; Yarchoan R; Wyvill K; Okamoto S; Little RF; Tosato G
Blood; 2001 Apr; 97(7):2173-6. PubMed ID: 11264189
[TBL] [Abstract][Full Text] [Related]
32. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?
Sodhi A; Montaner S; Gutkind JS
FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988
[TBL] [Abstract][Full Text] [Related]
33. Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis.
Gasperini P; Sakakibara S; Tosato G
J Leukoc Biol; 2008 Oct; 84(4):994-1000. PubMed ID: 18319288
[TBL] [Abstract][Full Text] [Related]
34. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2.
Albini A; Fontanini G; Masiello L; Tacchetti C; Bigini D; Luzzi P; Noonan DM; Stetler-Stevenson WG
AIDS; 1994 Sep; 8(9):1237-44. PubMed ID: 7528513
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders.
Aoki Y; Tosato G
Expert Rev Anti Infect Ther; 2004 Apr; 2(2):213-25. PubMed ID: 15482187
[TBL] [Abstract][Full Text] [Related]
36. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.
Du MQ; Liu H; Diss TC; Ye H; Hamoudi RA; Dupin N; Meignin V; Oksenhendler E; Boshoff C; Isaacson PG
Blood; 2001 Apr; 97(7):2130-6. PubMed ID: 11264181
[TBL] [Abstract][Full Text] [Related]
37. KSHV/HHV8-associated lymphoproliferations in the AIDS setting.
Schulz TF
Eur J Cancer; 2001 Jul; 37(10):1217-26. PubMed ID: 11423254
[TBL] [Abstract][Full Text] [Related]
38. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.
Hu D; Wang V; Yang M; Abdullah S; Davis DA; Uldrick TS; Polizzotto MN; Veeranna RP; Pittaluga S; Tosato G; Yarchoan R
J Virol; 2016 Jan; 90(1):368-78. PubMed ID: 26491160
[TBL] [Abstract][Full Text] [Related]
39. Involvement of vascular endothelial growth factor in Kaposi's sarcoma associated with acquired immunodeficiency syndrome.
Sakurada S; Kato T; Mashiba K; Mori S; Okamoto T
Jpn J Cancer Res; 1996 Nov; 87(11):1143-52. PubMed ID: 9045943
[TBL] [Abstract][Full Text] [Related]
40. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
